Moxifloxacin QD similar to piperacillin-tazobactam and amoxicillin-clavulanate dosed multiple times a day in treatment of complicated intra-abdominal infections.
- Published in:
- 2006
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2006 AND VI 41 AND IP 9
Results: 23
1
2
New data emerge on the relationship between diabetic, pre-diabetic conditions and Alzheimer's disease.
- Published in:
- 2006
- Publication type:
- Journal Article
3
Drug watch.
- Published in:
- 2006
- Publication type:
- Journal Article
4
A drug use evaluation of amphotericin B lipid complex injection following institution of new treatment guidelines at a tertiary teaching medical center.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
5
Management of epoetin alpha use in the intensive care unit: a drug use evaluation.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
6
Sitagliptin.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
7
Drug Watch.
- Published in:
- 2006
- Publication type:
- Product Review
8
FDA takes steps to automate drug registration; Plan B OTC availability still an area of contention.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 476
- By:
- Publication type:
- Article
9
Moxifloxacin QD similar to piperacillin-tazobactam and amoxicillin-clavulanate dosed multiple times a day in treatment of complicated intra-abdominal infections.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 469
- Publication type:
- Article
10
New data emerge on the relationship between diabetic, pre-diabetic conditions and Alzheimer's disease.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 469
- Publication type:
- Article
11
Raloxifene benefits in breast cancer, increases risk of fatal stroke.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 466
- Publication type:
- Article
12
Raloxifene fares as well as tamoxifen in 2 related comparison studies.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 466
- Publication type:
- Article
13
Elevated atorvastatin dosage reduces rate of cardiovascular events in CHD patients.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 463
- Publication type:
- Article
14
Atorvastation fails to demonstrate significant benefit in treatment of CV disease in patients with diabetes.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 463
- Publication type:
- Article
15
A drug use evaluation of amphotericin B lipid complex injection following institution of new treatment guidelines at a tertiary teaching medical center.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 450
- By:
- Publication type:
- Article
16
Management of epoetin alpha use in the intensive care unit: a drug use evaluation.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 442
- By:
- Publication type:
- Article
17
Sitagliptin.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 434
- By:
- Publication type:
- Article
18
Medication Safety in brief.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 432
- Publication type:
- Article
19
Alterations in mitochondrial function are likely cause of imatinib-induced cardiotoxicity.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 432
- Publication type:
- Article
20
Meta-analysis: Anticholinergics reduce COPD exacerbations more effectively than beta-2 agonists.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 430
- Publication type:
- Article
21
FDA: actions in brief.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 428
- Publication type:
- Article
22
New formulations.
- Published in:
- 2006
- Publication type:
- Product Review
23
New indications.
- Published in:
- 2006
- Publication type:
- Product Review